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Abstract
Background: Limited evidence exists to inform physical activity (PA) and sedentary behavior guidelines for older
people, especially women. Rigorous evidence on the amounts, intensities, and movement patterns associated with
better health in later life is needed.
Methods/Design: The Objective PA and Cardiovascular Health (OPACH) Study is an ancillary study to the Women’s
Health Initiative (WHI) Program that examines associations of accelerometer-assessed PA and sedentary behavior with
cardiovascular and fall events. Between 2012 and 2014, 7048 women aged 63–99 were provided with an ActiGraph GT3X
+ (Pensacola, Florida) triaxial accelerometer, a sleep log, and an OPACH PA Questionnaire; 6489 have accelerometer data.
Most women were in their 70s (40%) or 80s (46%), while approximately 10% were in their 60s and 4% were age 90 years
or older. Non-Hispanic Black or Hispanic/Latina women comprise half of the cohort. Follow-up includes 1-year of falls
surveillance with monthly calendars and telephone interviews of fallers, and annual follow-up for outcomes
with adjudication of incident cardiovascular disease (CVD) events through 2020. Over 63,600 months of
calendar pages were returned by 5,776 women, who reported 5,980 falls. Telephone interviews were
completed for 1,492 women to ascertain the circumstances, injuries and medical care associated with falling.
The dataset contains extensive information on phenotypes related to healthy aging, including inflammatory
and CVD biomarkers, breast and colon cancer, hip and other fractures, diabetes, and physical disability.
Discussion: This paper describes the study design, methods, and baseline data for a diverse cohort of postmenopausal
women who wore accelerometers under free-living conditions as part of the OPACH Study. By using accelerometers to
collect more precise and complete data on PA and sedentary behavior in a large cohort of older women, this study will
contribute crucial new evidence about how much, how vigorous, and what patterns of PA are necessary to maintain
optimal cardiovascular health and to avoid falls in later life.
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Background
Due to their longevity advantage, women outnumber
men in later life [1]. By the year 2060, the number of
women ages 65 years and older in the United States
(US) is estimated to be 52.7 million [2]. Despite their
greater longevity, women have more morbidity and
disability than men [3], resulting in higher frequency of
outpatient visits and hospitalizations, use of long-term
care services, and health care expenditures [4–6].
Regular physical activity (PA) provides remarkable
health benefits for older adults, including reducing the
risk of mortality, developing many chronic diseases,
functional limitations, and fall-related injuries [7]. The
2008 PA Guidelines for Americans recommends that
adults of all ages get a minimum of 150 min per week of
moderate-intensity aerobic activity [7], however,
accelerometer-measured PA data estimated that only 2%
of older Americans met this guideline [8] and they sat
up to 11 h per day [9–11]. Women, especially older
women, were underrepresented in the evidence reviewed
to derive these guidelines. This paper describes the study
design, methods, and baseline data for a diverse cohort
of postmenopausal women in the “Objective PA and
Cardiovascular Health in Older Women” (OPACH)
Study [R01 HL105065; PI: A LaCroix]. This study will
contribute crucial new evidence about how much, how
vigorous, and what patterns of PA are necessary to
maintain optimal cardiovascular health in later life and
whether PA levels are associated with incident falls.
Methods
Study population
The Women’s Health Initiative, Extension Studies and Long
Life Study
The OPACH Study is an ancillary study to the WHI study,
a major National Institutes of Health (NIH) research
program that began in the early 1990s. Postmenopausal
women ages 50 to 79 years were enrolled in the WHI
Clinical Trials or the Observational Study from 40 clinical
sites throughout the US from 1993 to 1998. Details about
WHI have been extensively described [12, 13]. Protocols
were approved by institutional review boards at participat-
ing institutions and all women gave written informed con-
sent. WHI participants continue to be followed annually
for disease events, changes in functional status, and death
through the main program that ended in 2005, and three
Extension Studies (2005–2010; 2010–2015; 2015–2020).
Enrollment in the Extension Studies required that eligible
women (alive and willing to be contacted) provide
informed consent for continued follow-up in WHI. In the
first Extension, 76.9% of 150,075 eligible women con-
sented to further follow-up. In the second Extension,
86.8% of 107,706 eligible women consented to further
follow-up without a defined end date.
The WHI Long Life Study was conducted during the
second WHI Extension Study among a subcohort of 7,875
WHI participants from March 2012 to May 2013 from all
40 original US clinical centers in their homes to collect
new data to support research on factors associated with
healthy aging and changing levels of biomarkers of CVD
risk. Data collection included a brief clinical assessment
(height, weight, waist circumference, blood pressure, and
pulse), assessment of functional status (Short Physical
Performance Battery (SPPB), [14, 15] and grip strength),
and phlebotomy.
A total of 7,048 WHI women who consented to partici-
pate in both the Long Life Study and the OPACH study
were provided with an ActiGraph GT3X+ (Pensacola,
Florida) triaxial accelerometer, a sleep log, and an OPACH
PA Questionnaire (Additional file 1) between March 2012
and April 2014 either during the home visit or via express
mail afterwards.
Cardiovascular disease outcomes
The primary outcomes for the OPACH Study are total
cardiovascular disease (CVD) events and total mortality.
WHI Extension Study participants are mailed forms annu-
ally to ascertain updates to their medical history. Medical
Table 1 Cardiovascular Disease and Mortality Outcomes Ascertainment in WHI
Study Outcome Definition and Confirmation of Outcomes
Non-fatal myocardial infarction Standardized criteria for diagnostic electrocardiography changes, elevated cardiac enzymes or both
Revascularization Documentation of the procedure in the medical record.
Angina Hospital record, angiography evidence, diagnostic stress test, or documented physician diagnosis and medical
treatment
Congestive heart failure Hospital record and diagnostic confirmatory tests
Fatal coronary heart disease Documentation in the hospital record, autopsy report or cause of death on the death certificate with evidence of
previous coronary heart disease
Stroke Documentation in the medical record of neurologic deficit of rapid onset consistent with stroke and lasting for at
least 24 h or until death
Death from other
cardiovascular disease
Confirmatory evidence in the medical records as ascertained by physician adjudicators
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records are obtained for reported outcomes and adjudi-
cated by trained study physicians. Definitions of CVD out-
comes are described in detail elsewhere [16] and
summarized in Table 1. Deaths are ascertained when a
family member informs the WHI staff, and through Na-
tional Death Index searches and obituary notices. Partici-
pants are followed until they die, are lost-to-follow-up, or
request no further contact. Vital status was known for
98% of women as of the end of 2014. Causes of death are
determined based on available medical records, autopsy
reports, and the death certificate in a blinded fashion by
local and central physician adjudicators.
OPACH falls surveillance and data collection
To monitor safety, the OPACH study conducted surveil-
lance on incident falls for one year after accelerometry
and collected information about all injuries and fall-
related injuries that required medical care. Incident falls
were ascertained using a 13-month calendar distributed
to OPACH participants to record daily if they had a fall
(“no fall” or “yes, I fell”). Calendar pages were sent back
monthly, data were entered and dates of reported falls
were tracked. Participants were mailed a reminder
postcard if calendars were not returned and, if a woman
lost or misplaced any calendar pages, a new calendar
Fig. 1 Strobe Diagram for Falls Surveillance in the OPACH Study
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was sent. The first month of each woman’s calendar
corresponded to the month that she wore the acceler-
ometer. Falls surveillance began in March 2012 and was
completed in March 2015.
When a fall was reported on a calendar page, participants
were interviewed by telephone about the circumstances of
the fall, including events leading up to the fall, physical activ-
ities (both leisure and non-leisure) engaged in at the time of
the fall, location of the fall (inside or outside of the home),
whether injuries resulted and, if so, the body region and type
of injury (particularly, any fractures), and the highest level of
medical care received for all injuries. For women who fell
multiple times within a month, data collection was limited
to the first two injury falls and first two non-injury falls. Par-
ticipants could be contacted multiple times if they reported
falling on more than one calendar page over the 13-month
follow-up period. Due to limited resources, beginning in
April 2013, interviews were conducted among 100% of falls
reported by the most physically active women - defined as
those in the highest quintile (≥21 MET-hours/week) of self-
reported total recreational PA - and 20% of falls reported
from all other women were selected to be interviewed [17].
Fig. 2 Strobe Diagram for Accelerometer Data in the OPACH Study
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As shown in Fig. 1, 6,580 women received a 13-month
calendar for falls surveillance, of whom, 6,118 (93%)
returned an accelerometer with usable data. Of these,
5,776 (94%) women returned at least 1 month of calen-
dar pages and 4,246 (69%) women returned 12–13
months of calendar pages. Among the over 63,600 pages
of calendar months returned, 5,980 falls were reported
and 3,375 of these falls were sent for interviews. A total
of 2,577 (76%) fall interviews were completed from
1,492 women, 416 (28%) of whom were among the most
physically active. Reasons that fall interviews were not
completed included that the participant did not remem-
ber falling, could not be contacted, refused the interview,
or was deceased.
Accelerometer data collection
The hip-worn accelerometer was placed at the iliac crest
and secured with a belt. Women were asked to wear the
accelerometer for 7 days during both waking and sleeping
hours, except when bathing or swimming, starting the day
after they complete their home visit or received their mailed
package. To isolate sleeping time, participants recorded time
in and out of bed on the OPACH sleep log [18]. The accel-
erometer was preset to begin data collection at a specified
date and time. The device provided no feedback to the
participant about their PA. As shown in Fig. 2, 6,721 (95%)
women returned their accelerometers and of these, 6,489
(92%) had some data for analysis. The 569 women who did
not return accelerometers with usable data were somewhat
more likely to be African-American, had poorer self-
reported health, lower physical function scores, higher levels
of depressive symptoms and higher prevalence of past
cardiovascular disease, but were less likely to report a fall in
the past year when compared to the women with acceler-
ometer data.
Accelerometer data processing
Accelerometer data were measured and saved at a rate of
30 times per second (i.e., at 30 hertz). When devices were
returned from participants, the data were downloaded and
saved for long-term storage. Over the data collection
phase of the study, the ActiGraph software (ActiLife)
versions 6.0.0 to 6.101 were used. Data were processed
using ActiLife Firmware v2.4 and the activity counts for
the three orthogonal axes at which acceleration was mea-
sured were output for every 15-s epoch using the normal
frequency filter mode and the low frequency filter mode,
separately. Data from the three axes were used to compute
the vector magnitude (VM) by taking the square root of
the sum of the vertical axis squared, the anterior-posterior
axis squared, and the medial-lateral axis squared.
A computer-based automated algorithm, in alignment
with the sleep logs and visual inspection, was used to
identify the window of days with the maximum amount
wear over a consecutive 7 day period [18]. When available,
the sleep log data were used to identify periods when the
participant reported being out of bed (vs. in bed). To
maximize the use of accelerometer data when sleep logs
were missing or were suspected to have reporting error,
mean values for in-bed and out-of-bed times were
imputed for each participant if at least one day of sleep
log data were recorded. Population mean in-bed and out-
of-bed times were used for women with no sleep log data.
Table 2 Summary and sources of measures used in OPACH Physical Activity Questionnaire
Survey Measure Question
Number
Source (within References)
WHI self-reported physical activity 1–4 [17]
Borg scale assessment of relative intensity 5 [32]
Rating of perceived capacity scale 6–7 [33]
WHI self-reported sedentary behavior 8–10 [17]
CARDIA study sedentary behavior scale 11–12 [34, 35]
Short Falls Efficacy Scale International 13 [36]
Participation in falls prevention programs 18–19 Original, newly developed
questions
Falls history assessment 20–21 [37]
Engagement in physical activity during fall and injurious fall; injurious fall history assessment 22–26 Original, newly developed
questions
Urban environment and physical activity 27 [38]
Neighborhood Environmental Walkability Scale - select subscales (neighborhood type and
crime safety)
28–29 [39]
CHAMPS self-reported physical activity assessment 30 [40]
Abbreviations: CARDIA Coronary Artery Risk Development in Young Adults, CHAMPS Community Health Activities Model Program for Seniors, WHI Women’s
Health Initiative
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Fig. 3 a Traditional vs. OPACH Calibration Study Cutpoints for Sedentary Behavior. b Traditional vs. OPACH Calibration Study Cutpoints for
Moderate-to-Vigorous Intensity Physical Activity
Table 3 Categorization of Physical Activity Intensity Levels for Older Women in the OPACH Calibration Study
Intensity Level Vector Magnitude Cutpoint Values (counts per 15-s)
Sedentary 0–18
Low light 19–225
High light 226–518
Moderate-to-Vigorous ≥519
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Table 4 Baseline characteristics of OPACH participants by age group
Age Group, years
Total 63–69 70–79 80–89 90+ p-value
N (%) 6489 666 (10.3) 2600 (40.1) 2953 (45.5) 270 (4.2)
Race/Ethnicity, n (%)
Non-Hispanic White 3205 (49.4) 94 (2.9) 697 (21.8) 2192 (68.4) 222 (6.9) <0.001
Non-Hispanic Black 2187 (33.7) 373 (17.1) 1264 (57.8) 511 (23.4) 39 (1.8)
Hispanic/Latina 1097 (16.9) 199 (18.1) 639 (58.3) 250 (22.8) 9 (0.8)
Education, n (%)
High School or less 1316 (20.4) 101 (7.7) 499 (37.9) 652 (49.5) 64 (4.9) 0.002
Some College 2496 (38.7) 267 (10.7) 1024 (41.0) 1111 (44.5) 94 (3.8)
College Graduate or more 2634 (40.9) 293 (11.1) 1056 (40.1) 1174 (44.6) 111 (4.2)
Current Smoker, n (%) 164 (2.8) 35 (21.3) 81 (49.4) 47 (28.7) 1 (0.6) <0.001
Alcohol Use, n (%)
Non-drinker 2230 (37.9) 203 (9.1) 912 (40.9) 1022 (45.8) 93 (37.8) 0.12
< 1 drink per week 2008 (34.1) 210 (10.5) 820 (40.8) 889 (44.3) 89 (36.2)
≥ 1 drink per week 1651 (28.0) 176 (10.7) 617 (37.4) 794 (48.1) 61 (26.0)
Excellent or Very Good Self-Rated
Health, n (%)
2977 (50.8) 338 (11.4) 1216 (40.9) 1321 (44.4) 102 (3.4) <0.001
RAND SF-36 Physical Function Score,
mean (SD)
67.9 (26.0) 78.9 (23.1) 73.0 (25.0) 62.5 (25.3) 48.3 (25.3) <0.001
Depressive Symptoms Score,
mean (SD)
0.03 (0.11) 0.04 (0.15) 0.03 (0.12) 0.02 (0.09) 0.01 (0.07) <0.001
Self-Reported Physical Activity,
MET-hrs/week, mean (SD)
11.9 (14.0) 15.0 (16.5) 13.3 (14.8) 10.4 (12.8) 6.6 (8.9) <0.001
CHAMPS Expenditure,
MET-hrs/week, mean (SD)
29.1 (26.8) 34.8 (32.2) 31.7 (29.0) 26.5 (23.4) 18.9 (18.3) <0.001
CARDIA Scale, sedentary
hours/week, mean (SD)
56.4 (22.7) 58.3 (25.3) 57.8 (24.1) 54.7 (20.6) 54.7 (20.9) <0.001
Falls in past 12 months, n (%)
None 4503 (69.4) 493 (11.0) 1870 (41.5) 1974 (43.8) 166 (3.7) <0.001
One time 1258 (19.4) 112 (8.9) 484 (38.5) 602 (47.9) 60 (4.8)
Two or more times 728 (11.2) 61 (8.4) 246 (33.8) 377 (51.8) 44 (6.0)
Falls Efficacy Score, mean (SD) 10.7 (4.2) 9.6 (3.8) 10.1 (3.8) 11.3 (4.3) 13.3 (5.1) <0.001
Short Physical Performance Battery
score, mean (SD)
8.2 (2.5) 9.2 (2.1) 8.6 (2.3) 7.7 (2.6) 6.5 (2.9) <0.001
Systolic Blood Pressure, mean (SD) 125.7 (14.3) 122.6 (12.9) 125.2 (13.8) 126.6 (14.7) 127.9 (16.4) <0.001
Diastolic Blood Pressure, mean (SD) 72.5 (8.8) 73.6 (8.1) 73.3 (8.6) 71.8 (9.0) 71.0 (9.2) <0.001
Waist, inches, mean (SD) 35.5 (5.5) 36.1 (5.5) 36.1 (5.7) 35.0 (5.2) 33.8 (5.1) <0.001
Weight, lbs, mean (SD) 158.4 (34.4) 171.8 (37.5) 166.1 (35.9) 150.6 (30.0) 138.3 (25.9) <0.001
Body Mass Index, kg/m2, mean (SD) 28.2 (5.8) 29.9 (6.2) 29.3 (6.1) 27.1 (5.2) 25.9 (4.8) <0.001
Body Mass Index Categories, n (%)
< 25 kg/m2 1944 (32.1) 128 (6.6) 627 (32.3) 1065 (54.8) 124 (6.4) <0.001
25–<30 kg/m2 2199 (36.3) 209 (9.5) 868 (39.5) 1032 (46.9) 90 (4.1)
≥ 30 kg/m2 1917 (31.6) 259 (13.5) 938 (48.9) 677 (35.3) 43 (2.2)
Medical History
Stroke 459 (7.1) 21 (4.6) 134 (29.2) 271 (59.0) 33 (7.2) <0.001
Congestive Heart Failure 133 (2.1) 9 (6.8) 41 (30.8) 73 (54.9) 10 (7.5) 0.013
Total CVD 1327 (20.5) 92 (6.9) 472 (35.6) 687 (51.8) 76 (5.7) <0.001
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Automated methods for identifying in-bed periods are
currently being explored [19, 20].
Accelerometer non-wear was defined by an interval of at
least 90 consecutive minutes of zero VM counts per
minute, with allowance for 2-min windows including non-
zero VM counts as long as no counts were detected during
the 30 min upstream and downstream of each window and
that the cumulative duration of consecutive upstream and
downstream zeros were ≥90 min [21, 22]. Any nonzero
VM counts (except the allowed short intervals) were
considered wear time.
An adherent day was defined as ≥10 h of accelerometer
wear time during periods the participant was out-of-bed.
Covariate data collection
The OPACH PA Questionnaire [see Additional File 1] was
completed by women in their homes and mailed back to
the WHI Clinical Coordinating Center for data entry.
Table 2 (below) summarizes the measures included in the
questionnaire and the origin of validated scales.
The health status of OPACH participants has been exten-
sively and continuously characterized since their WHI
enrollment in 1993–1998. Information was collected by
interview and/or self-administered questionnaires for all
participants on age, race/ethnicity, education, age at meno-
pause, hormone therapy use, medication use (e.g., statins,
lipid-lowering drugs, antihypertensive drugs), treated
diabetes, personal and parental history of major chronic
diseases, and physical functioning using the RAND SF-36
instrument [23]. A medication inventory was collected by
mail just prior to the start of the Long Life Study.
As part of the Long Life Study protocol, a fasting blood
draw was collected during the participant’s home visit.
Biomarkers (glucose, insulin, creatinine, high-sensitivity
C-reactive protein, high and low density lipoprotein chol-
esterol, triglyceride, total cholesterol) were measured at
the University of Minnesota. Of the 7,875 Long Life Study
participants, 7,325 (93%) have biomarker data available.
Of these, 5,100 (70%) participated in the OPACH study.
OPACH calibration study
No standard was available to classify intensity of PA, and
to distinguish sedentary behavior from light PA, using
accelerometer data in older adults. Therefore, we con-
ducted a separate laboratory-based calibration study in
women ages 60 to 91 years to determine accelerometer
count cutpoints that best distinguish levels of PA volume
intensity in older women. Details of the calibration study
design and results have been published previously [24].
Traditional accelerometer cutpoints were found to be
too high for older women resulting in PA being underesti-
mated [11, 25]. Traditional cutpoints were derived using
vertical axis accelerometer counts, so Fig. 3a and b present
OPACH vertical axis count cutpoints to allow for accurate
comparisons. Figure 3a displays two different vertical axis
count cutpoints for light intensity PA in OPACH calibra-
tion study participants. The traditional cutpoint for seden-
tary behavior of <100 counts per minute on the vertical
axis [10] results in more light intensity PA minutes being
misclassified as sedentary (false negatives) causing an
underestimation of light intensity PA minutes and over-
estimation of sedentary minutes among OPACH partici-
pants. Similarly, Fig. 3b shows that the vertical axis count
cutpoint for moderate-to-vigorous PA (MVPA) from the
calibration study (> = 1320 counts/minute) was lower than
a commonly used cutpoint (> = 1952 counts/minute) [26].
Again, using the higher cutpoint would cause an under-
estimation of MVPA for women in the OPACH study.
The OPACH Calibration Study reported intensity
cutpoints derived from different methods of analyzing
the data [24]. OPACH chose the method that defined a
MET as 3.0 ml/kg/min and with data processed using
the normal frequency filter, where cutpoints were
derived by balancing false positive and false negatives. A
MET value of 3.0 ml/kg/min is slightly lower than the
traditionally defined value of 1 MET = 3.5 ml/kg/min,
but better reflects observed resting energy expenditure
of older adults studied with indirect calorimetry [24, 27,
28]. This resulted in the categorization of PA intensity as
shown in Table 3.
Baseline characteristics
Table 4 describes demographic, health behavior and
health status characteristics by four age groups for the
6,489 women with accelerometer data. Most women were
in their 70s (40%) or 80s (46%), while approximately 10%
Table 4 Baseline characteristics of OPACH participants by age group (Continued)
Hip fracture 188 (2.9) 4 (2.1) 24 (12.8) 133 (70.7) 27 (14.4) <0.001
Any clinical fracture 2202 (33.9) 150 (6.8) 775 (35.2) 1156 (52.5) 121 (5.5) <0.001
Diabetes 2078 (32.0) 237 (11.4) 933 (44.9) 846 (40.7) 62 (3.0) <0.001
Osteoarthritis 4000 (61.6) 404 (10.1) 1599 (40.0) 1817 (45.4) 180 (4.5) 0.36
Invasive cancer 992 (15.3) 72 (7.3) 391 (39.4) 488 (49.2) 41 (4.1) 0.003
Breast cancer 480 (7.4) 44 (9.2) 216 (45.0) 202 (42.1) 18 (3.8) 0.15
Abbreviations: CARDIA Coronary Artery Risk Development in Young Adults, CHAMPS Community Health Activities Model Program for Seniors, CVD cardiovascular
disease, MET Metabolic equivalents, OPACH Objective Physical Activity and Cardiovascular Health, SD Standard deviation
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Table 5 Baseline characteristics of 6,126 OPACH participants by quartiles of accelerometer measured physical activity
Quartiles of average VM per 15-s epoch (adherent days only)
Total <70.7 70.7–<95.2 95.2–<126.0 ≥126.0 p-value
Age group, years, n (%)
63–69 627 (10.2) 67 (10.7) 98 (15.6) 169 (27.0) 293 (46.7) <0.001
70–79 2448 (40.0) 417 (17.0) 600 (24.5) 664 (27.1) 767 (31.3)
80–89 2794 (45.6) 908 (32.5) 767 (27.5) 663 (23.7) 456 (16.3)
90+ 257 (4.2) 139 (54.1) 67 (26.1) 36 (14.0) 15 (5.8)
Race/Ethnicity, n (%)
Non-Hispanic White 3046 (49.7) 911 (29.9) 779 (25.6) 726 (23.8) 630 (20.7) <0.001
Non-Hispanic Black 2047 (33.4) 489 (23.9) 541 (26.4) 519 (25.4) 498 (24.3)
Hispanic/Latina 1033 (16.9) 131 (12.7) 212 (20.5) 287 (27.8) 403 (39.0)
Education, n (%)
High School or less 1237 (20.3) 311 (25.1) 315 (25.5) 307 (24.8) 304 (24.6) 0.05
Some College 2349 (38.6) 620 (26.4) 610 (26.0) 555 (23.6) 564 (24.0)
College Graduate or more 2499 (41.1) 590 (23.6) 593 (23.7) 655 (26.2) 661 (26.5)
Current Smoker, n (%) 159 (2.9) 58 (36.5) 38 (23.9) 38 (23.9) 25 (15.7) 0.001
Alcohol Use, n (%)
Non-drinker 2089 (37.4) 589 (28.2) 571 (27.3) 500 (23.9) 429 (20.5) <0.001
< 1 drink per week 1912 (34.2) 477 (25.0) 479 (25.1) 490 (25.6) 466 (24.4)
≥ 1 drink per week 1589 (28.4) 290 (18.3) 342 (21.5) 429 (27.0) 528 (33.2)
Excellent or Very Good Self-Rated Health, n (%) 2852 (51.3) 469 (16.4) 665 (23.3) 781 (27.4) 937 (32.9) <0.001
RAND SF-36 Physical Function Score, mean (SD) 68.2 (25.8) 50.4 (26.5) 66.0 (24.7) 73.4 (22.0) 82.0 (18.6) <0.001
Depressive Symptoms Score, mean (SD) 0.03 (0.11) 0.03 (0.12) 0.03 (0.10) 0.02 (0.10) 0.02 (0.10) 0.31
Self-Reported Physical Activity, MET-hrs/week, mean (SD) 12.0 (14.1) 6.3 (9.1) 9.9 (11.1) 13.3 (13.9) 18.4 (17.6) <0.001
CHAMPS Expenditure, MET-hrs/week, mean (SD) 29.4 (26.9) 18.8 (18.1) 25.0 (20.7) 32.4 (27.4) 41.0 (33.3) <0.001
CARDIA Scale, sedentary hours/week, mean (SD) 56.3 (22.6) 63.2 (23.0) 58.4 (22.6) 54.6 (21.8) 49.6 (20.7) <0.001
Falls in past 12 months, n (%)
None 4256 (69.5) 1010 (23.7) 1065 (25.0) 1068 (25.1) 1113 (26.2) <0.001
One time 1195 (19.5) 298 (24.9) 307 (25.7) 307 (25.7) 283 (23.7)
Two or more times 675 (11.0) 223 (33.0) 160 (23.7) 157 (23.3) 135 (20.0)
Falls Efficacy Score, mean (SD) 10.7 (4.1) 12.6 (4.9) 10.6 (3.8) 10.2 (3.7) 9.4 (3.3) <0.001
Short Physical Performance Battery score, mean (SD) 8.2 (2.5) 6.8 (2.7) 8.1 (2.4) 8.7 (2.2) 9.3 (2.1) <0.001
Systolic Blood Pressure, mean (SD) 125.7 (14.3) 128.1 (15.2) 126.4 (14.5) 125.2 (14.0) 123.2 (13.2) <0.001
Diastolic Blood Pressure, mean (SD) 72.5 (8.8) 73.1 (9.5) 72.6 (8.9) 72.3 (8.6) 72.1 (8.0) 0.03
Waist, inches, mean (SD) 35.4 (5.5) 37.4 (5.9) 36.0 (5.2) 34.9 (5.2) 33.3 (4.6) <0.001
Weight, lbs, mean (SD) 157.9 (34.1) 166.9 (38.2) 160.3 (34.8) 155.9 (31.6) 148.8 (28.5) <0.001
Body Mass Index, kg/m2, mean (SD) 28.1 (5.7) 29.7 (6.3) 28.7 (5.7) 27.7 (5.5) 26.4 (4.8) <0.001
Body Mass Index Categories, n (%)
< 25 kg/m2 1868 (32.5) 328 (17.6) 400 (21.4) 495 (26.5) 645 (34.5) <0.001
25–<30 kg/m2 2076 (36.2) 474 (22.8) 524 (25.2) 562 (27.1) 516 (24.9)
≥ 30 kg/m2 1796 (31.3) 597 (33.2) 516 (28.7) 395 (22.0) 288 (16.0)
Medical History
Stroke 427 (7.0) 164 (38.4) 123 (28.8) 79 (18.5) 61 (14.3) <0.001
Congestive Heart Failure 124 (2.0) 67 (54.0) 26 (21.0) 22 (17.7) 9 (7.3) <0.001
Total CVD 1234 (20.1) 441 (35.7) 329 (26.7) 273 (22.1) 191 (15.5) <0.001
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were in their 60s and 4% were age 90 years or older. Non-
Hispanic Black and Hispanic/Latina women represented
half of the sample and were generally younger than the
Non-Hispanic White women in the study. Physical func-
tioning, measured both through the RAND SF-36 survey
[23] and the SPPB test [14], decreased as age increased.
Likewise, self-reported PA levels decreased across incre-
mental age groups. As women aged, they were more likely
to have fallen in the past year and were more concerned
about falling in the future. Average resting systolic blood
pressure (SBP) was higher as age increased; however, aver-
age resting diastolic blood pressure, waist circumference,
weight, and body mass index (BMI) were lower.
Of the 6,489 women with accelerometer data, 6,126
wore the accelerometer while out of bed for at least
4 days for at least 10 h each day. Table 5 shows the
characteristics of adherent women by quartiles of
average VM counts per 15-s epoch. Consistent with
the self-reported PA levels in Table 4, younger
women had higher levels of PA. White women were
more likely (30%) to be in the lowest PA quartile
compared with Black women (24%) and Hispanic/La-
tina women (13%). Women in the highest quartile of
PA had a higher frequency of excellent or very good
self-rated health (33 vs. 16% among women in the
lowest quartile of PA) and of not falling in the past
year. Furthermore, physical functioning and self-
reported PA were higher and average SBP, waist cir-
cumference, weight, and BMI were lower among
women in the highest quartile of PA.
Discussion
The OPACH Study is one of the first, large prospect-
ive studies in older women to measure PA objectively
using a state-of-the-science triaxial accelerometer.
The cohort is unique in its diversity (2,187 Non-
Hispanic Black and 1,097 Hispanic/Latina women)
and in the richness of adjudicated CVD, cancer, hip
fracture and other outcomes. Moreover, physical func-
tion, activities of daily living disability, quality of life,
and incident hospitalizations are being measured
annually through at least the year 2020.
The OPACH study will address gaps in knowledge
about PA, falls, and fall-related injuries. Injuries are the
most common adverse event from participation in PA
[7]. However, evidence is limited about how overall risk
of major injuries requiring medical care depends upon
level of PA [29]. Despite an extensive literature on exer-
cise and falls in older adults [30], there are no data
quantifying fall and fall-related injury risk in relation to
accelerometer-measured PA in older women. RCT data
clearly show that exercise programs reduce risk of falls
in older adults [7], but it is unknown whether these pro-
grams might increase risk of other types of injury, for
example, through increased exposure to road traffic as
an exercising pedestrian. Observational data in older
populations performing their usual activities (as opposed
to a supervised intervention) are needed to characterize
more completely both the benefits and risks of PA,
particularly the habitual low levels of PA not typically
captured by self-reported questionnaires.
The OPACH Calibration study results clearly showed
that traditional cutpoints underestimate the amount of
MVPA and overestimate sedentary time in older women
[24]. Although we are providing novel information on
age and gender appropriate intensity cutpoints for PA,
we were unable to design a study that would provide
individualized “relative-intensity” cutpoints that account
for individual cardiorespiratory fitness. This is an im-
portant direction for future research. Our capture of raw
accelerometer data in this large population is leading to
novel uses of that go beyond defining intensity levels to
capture types of PA (walking, sit-to-stand transitions,
standing time) using machine-learning algorithms [31],
latent class patterns of PA and sedentary behavior, and
other inventive summaries. We strongly recommend the
capture and storage of raw accelerometer data in all
future studies so that new strategies for analyzing the
data can be further developed and employed.
The OPACH Study is a cost-effective approach to
creating an unparalleled dataset for understanding the
health benefits of PA for older women. Our primary
objectives focus first on CVD health and falls in older
women. However, the addition of accelerometer data to
the WHI Program will have tremendous value in
Table 5 Baseline characteristics of 6,126 OPACH participants by quartiles of accelerometer measured physical activity (Continued)
Hip fracture 177 (2.9) 72 (40.7) 49 (27.7) 39 (22.0) 17 (9.6) <0.001
Any clinical fracture 2060 (33.6) 580 (28.2) 508 (24.7) 508 (24.7) 464 (22.5) <0.001
Diabetes 1928 (31.5) 603 (31.3) 529 (27.4) 442 (22.9) 354 (18.4) <0.001
Osteoarthritis 3748 (61.2) 974 (26.0) 960 (25.6) 930 (24.8) 884 (23.6) 0.005
Invasive cancer 942 (15.4) 292 (31.0) 252 (26.8) 220 (23.4) 178 (18.9) <0.001
Breast cancer 457 (7.5) 138 (30.2) 124 (27.1) 99 (21.7) 96 (21.0) 0.009
Abbreviations: CARDIA Coronary Artery Risk Development in Young Adults, CHAMPS Community Health Activities Model Program for Seniors, CVD Cardiovascular
disease, MET Metabolic equivalents, OPACH Objective Physical Activity and Cardiovascular Health, SD Standard deviation
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studying other phenotypes related to healthy aging, in-
cluding inflammatory biomarkers, breast and colon can-
cer, diabetes, and physical disability.
Additional files
Additional file 1: OPACH PA Questionnaire. (DOCX 351 kb)
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